Hyperfine, Inc.
NASDAQ Global MarketRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- Hyperfine, Inc. (Nasdaq: HYPR) develops, manufactures, and commercializes portable magnetic resonance imaging (MRI) systems for point-of-care brain imaging; its flagship Swoop Portable MR Imaging System, powered by Optive AI software, operates at ultra-low field strength (0.064T) to produce diagnostic-quality images including T1, T2, FLAIR, and DWI sequences in axial, coronal, and sagittal planes without requiring specialized infrastructure or shielding; the company also provides Hyperfine Image Viewer cloud platform for image archiving and management, technical support services, and software updates. Founded in 2014 by Jonathan Rothberg and headquartered in Guilford, Connecticut, Hyperfine targets hospitals (ICUs, emergency departments, neurology), clinics, pediatrics, stroke centers, and research institutions with its wheeled, AI-enhanced systems that enable bedside scanning globally. In 2025, Hyperfine secured FDA clearance and launched commercial sales of its next-generation Swoop system with Optive AI for substantially improved image quality; introduced the PULSE platform to accelerate AI-powered MRI adoption; announced first patient enrollments in PRIME, PRISM PMR, and NEURO PMR clinical studies evaluating portable MRI in emergency departments, operating rooms, and neurology offices; received a $3.7 million grant for global brain health initiatives and a CE Mark/UKCA approval for Optive AI to expand in Europe; expanded distribution partnerships in Turkey, Israel, Saudi Arabia, India, and additional European/Middle Eastern markets; and completed $17.5 million and $6.0 million offerings to support commercialization, manufacturing, and R&D.
Company News
Hyperfine, Inc. to Participate in Lake Street Capital Markets 10th Annual Best Ideas Growth Conference
Hyperfine Builds Momentum in Year One of Neurology Office Launch with NEURO PMR Publication and More Than 3,000 Scans
Hyperfine Builds Momentum in Year One of Neurology Office Launch with NEURO PMR Publication and More Than 3,000 Scans
Hyperfine Announces FDA Clearance of the Next Optive AI™ Software, Further Enhancing Image Quality, Clinical Utility, and Ease of Use of the Swoop® System Across Care Settings
Hyperfine Announces FDA Clearance of the Next Optive AI™ Software, Further Enhancing Image Quality, Clinical Utility, and Ease of Use of the Swoop® System Across Care Settings
Hyperfine, Inc. (HYPR) Q2 2026 Earnings Call Transcript
Hyperfine Q2 Earnings Call Highlights
Hyperfine, Inc. Reports Second Quarter 2026 Financial Results
Hyperfine Announces the Release of Multiple Peer-Reviewed Publications, Expanding Clinical Evidence for the Swoop® System Across a Growing Number of Sites of Care
Hyperfine, Inc. to Announce Second Quarter 2026 Financial Results on August 6, 2026
Hyperfine Announces European Launch of Next-Generation Swoop® System
Hyperfine Forms Global Neurosurgery Advisory Council to Support Expansion of Portable MRI in Neurosurgical Care
Hyperfine Swoop® System Scan Volume in the United States Hits Record Milestones Across Multiple Sites of Care
Hyperfine Swoop® System Scan Volume in the United States Hits Record Milestones Across Multiple Sites of Care
Hyperfine, Inc. (HYPR) Presents at Jefferies Global Healthcare Conference 2026 Prepared Remarks Transcript
Hyperfine to Join Russell 2000® and Russell 3000® Indexes
Hyperfine to Join Russell 2000® and Russell 3000® Indexes
Hyperfine Announces Presentation of Results from the PRIME Study Showing Portable MRI Substantially Reduces Time to Imaging in Emergency Departments
Hyperfine, Inc. (HYPR) Q1 2026 Earnings Call Transcript
Hyperfine Q1 Earnings Call Highlights